Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plant Extracts | 7 | 2019 | 286 | 1.660 |
Why?
|
| Nocturnal Enuresis | 1 | 2023 | 1 | 0.890 |
Why?
|
| Capparis | 2 | 2012 | 2 | 0.790 |
Why?
|
| Low Back Pain | 1 | 2022 | 92 | 0.790 |
Why?
|
| Cyclobutanes | 1 | 2021 | 2 | 0.770 |
Why?
|
| Fruit | 3 | 2012 | 173 | 0.770 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 2021 | 6 | 0.770 |
Why?
|
| Anti-Obesity Agents | 1 | 2021 | 10 | 0.760 |
Why?
|
| Phytotherapy | 2 | 2012 | 81 | 0.760 |
Why?
|
| Heart Diseases | 1 | 2021 | 104 | 0.690 |
Why?
|
| Action Potentials | 1 | 2021 | 231 | 0.670 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 166 | 0.660 |
Why?
|
| Hypericum | 2 | 2007 | 4 | 0.590 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 86 | 0.510 |
Why?
|
| Fibrinolytic Agents | 2 | 2012 | 25 | 0.480 |
Why?
|
| Isoxazoles | 1 | 2013 | 11 | 0.470 |
Why?
|
| Methanol | 2 | 2012 | 18 | 0.470 |
Why?
|
| Diabetic Neuropathies | 1 | 2013 | 11 | 0.470 |
Why?
|
| Hyperalgesia | 1 | 2013 | 18 | 0.470 |
Why?
|
| Anticonvulsants | 1 | 2013 | 34 | 0.460 |
Why?
|
| Thrombosis | 2 | 2012 | 63 | 0.460 |
Why?
|
| Edema | 1 | 2012 | 23 | 0.420 |
Why?
|
| Ethanol | 3 | 2011 | 192 | 0.410 |
Why?
|
| Lythraceae | 1 | 2011 | 3 | 0.400 |
Why?
|
| Crataegus | 1 | 2010 | 1 | 0.390 |
Why?
|
| Research | 1 | 2011 | 163 | 0.360 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 149 | 0.360 |
Why?
|
| Rats, Wistar | 3 | 2021 | 233 | 0.360 |
Why?
|
| Computer Simulation | 2 | 2011 | 362 | 0.360 |
Why?
|
| Analgesics | 1 | 2010 | 54 | 0.350 |
Why?
|
| Animals | 11 | 2023 | 15081 | 0.340 |
Why?
|
| Pain Measurement | 1 | 2010 | 171 | 0.340 |
Why?
|
| Models, Biological | 1 | 2011 | 677 | 0.310 |
Why?
|
| Antioxidants | 1 | 2011 | 416 | 0.310 |
Why?
|
| Caffeine | 1 | 2007 | 28 | 0.290 |
Why?
|
| Apoptosis | 2 | 2011 | 1398 | 0.290 |
Why?
|
| Tremor | 1 | 2006 | 9 | 0.290 |
Why?
|
| Mice | 6 | 2023 | 5913 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2013 | 1039 | 0.270 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2006 | 107 | 0.260 |
Why?
|
| Motor Activity | 2 | 2011 | 418 | 0.260 |
Why?
|
| Nitric Oxide | 1 | 2007 | 316 | 0.250 |
Why?
|
| Movement | 2 | 2022 | 97 | 0.240 |
Why?
|
| Rats | 3 | 2021 | 3483 | 0.220 |
Why?
|
| Urinary Bladder | 1 | 2023 | 29 | 0.220 |
Why?
|
| Range of Motion, Articular | 1 | 2022 | 31 | 0.220 |
Why?
|
| Physical Examination | 1 | 2023 | 43 | 0.220 |
Why?
|
| Posture | 1 | 2023 | 58 | 0.220 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 31 | 0.220 |
Why?
|
| Carrageenan | 2 | 2012 | 12 | 0.200 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 96 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2021 | 364 | 0.170 |
Why?
|
| Hyperkinesis | 2 | 2011 | 7 | 0.170 |
Why?
|
| Databases, Factual | 2 | 2011 | 291 | 0.170 |
Why?
|
| Antithrombins | 1 | 2019 | 3 | 0.170 |
Why?
|
| Hemostatics | 1 | 2019 | 8 | 0.170 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 461 | 0.160 |
Why?
|
| Motion | 1 | 2017 | 27 | 0.150 |
Why?
|
| Time Factors | 2 | 2021 | 1742 | 0.150 |
Why?
|
| Calcium | 1 | 2021 | 480 | 0.150 |
Why?
|
| Humans | 7 | 2023 | 37093 | 0.150 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2016 | 61 | 0.140 |
Why?
|
| Male | 5 | 2021 | 20025 | 0.130 |
Why?
|
| Child | 1 | 2023 | 3131 | 0.120 |
Why?
|
| Ondansetron | 1 | 2013 | 3 | 0.120 |
Why?
|
| Ketanserin | 1 | 2013 | 4 | 0.120 |
Why?
|
| Carbamazepine | 1 | 2013 | 5 | 0.120 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2013 | 7 | 0.120 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2013 | 5 | 0.120 |
Why?
|
| Streptozocin | 1 | 2013 | 21 | 0.120 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2013 | 16 | 0.120 |
Why?
|
| Morphine | 1 | 2013 | 85 | 0.110 |
Why?
|
| Flowers | 1 | 2012 | 16 | 0.100 |
Why?
|
| Dinoprostone | 1 | 2012 | 63 | 0.100 |
Why?
|
| Picrates | 1 | 2011 | 8 | 0.100 |
Why?
|
| Molybdenum | 1 | 2011 | 14 | 0.100 |
Why?
|
| Ellagic Acid | 1 | 2011 | 4 | 0.100 |
Why?
|
| Tungsten Compounds | 1 | 2011 | 15 | 0.100 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 53 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 77 | 0.100 |
Why?
|
| Agmatine | 1 | 2011 | 17 | 0.100 |
Why?
|
| Phenols | 1 | 2011 | 80 | 0.090 |
Why?
|
| Plant Leaves | 1 | 2010 | 124 | 0.090 |
Why?
|
| Curcumin | 1 | 2010 | 74 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2010 | 399 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 421 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1371 | 0.080 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 75 | 0.080 |
Why?
|
| Arginine | 1 | 2007 | 73 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1207 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 1 | 2007 | 128 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1015 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1198 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2231 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2006 | 314 | 0.060 |
Why?
|
| Female | 2 | 2013 | 20969 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1502 | 0.050 |
Why?
|
| Iron | 1 | 2019 | 225 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2010 | 32 | 0.020 |
Why?
|
| Leukemia | 1 | 2010 | 56 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2010 | 207 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2009 | 62 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2009 | 82 | 0.020 |
Why?
|
| Internet | 1 | 2009 | 211 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 864 | 0.020 |
Why?
|